We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.5B
AUM Growth
+$219M
Cap. Flow
+$156M
Cap. Flow %
10.37%
Top 10 Hldgs %
19.84%
Holding
2,472
New
220
Increased
918
Reduced
391
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 6.53%
2 Energy 6.29%
3 Industrials 6.24%
4 Healthcare 5.52%
5 Financials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJI
1126
DELISTED
South Jersey Industries, Inc.
SJI
$56K ﹤0.01%
1,604
BIP icon
1127
Brookfield Infrastructure Partners
BIP
$18.4B
$55K ﹤0.01%
2,325
+675
+41% +$16.1K
FEZ icon
1128
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.52B
$55K ﹤0.01%
1,450
-756
-34% -$29.2K
NWBI icon
1129
Northwest Bancshares
NWBI
$2.32B
$55K ﹤0.01%
3,200
RGLD icon
1130
Royal Gold
RGLD
$17.1B
$55K ﹤0.01%
725
+100
+16% +$8.23K
RPM icon
1131
RPM International
RPM
$14.2B
$55K ﹤0.01%
855
TTD icon
1132
Trade Desk
TTD
$8.6B
$55K ﹤0.01%
3,700
TU icon
1133
Telus
TU
$15.1B
$55K ﹤0.01%
3,020
+1,520
+101% +$27.8K
WEAT icon
1134
Teucrium Wheat Fund
WEAT
$295M
$55K ﹤0.01%
1,760
+1,260
+252% +$41.3K
FSGS
1135
First Trust SMID Growth Strength ETF
FSGS
$32M
$55K ﹤0.01%
2,400
RSX
1136
DELISTED
VanEck Russia ETF
RSX
$55K ﹤0.01%
2,577
-2,388
-48% -$49.4K
GWPH
1137
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$55K ﹤0.01%
321
-18
-5% -$2.6K
AOS icon
1138
A.O. Smith
AOS
$8.25B
$54K ﹤0.01%
1,013
AVB icon
1139
AvalonBay Communities
AVB
$27B
$54K ﹤0.01%
300
+16
+6% +$2.86K
CHY
1140
Calamos Convertible and High Income Fund
CHY
$1.02B
$54K ﹤0.01%
4,071
+2,565
+170% +$33.5K
FYT icon
1141
First Trust Small Cap Value AlphaDEX Fund
FYT
$195M
$54K ﹤0.01%
1,420
LXP icon
1142
LXP Industrial Trust
LXP
$3.56B
$54K ﹤0.01%
1,324
+890
+205% +$38.9K
PHD
1143
DELISTED
Pioneer Floating Rate Fund
PHD
$54K ﹤0.01%
4,955
SHYG icon
1144
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$54K ﹤0.01%
1,165
+500
+75% +$23.4K
FPX icon
1145
First Trust US Equity Opportunities ETF
FPX
$1.54B
$53K ﹤0.01%
725
-608
-46% -$44.8K
IEUR icon
1146
iShares Core MSCI Europe ETF
IEUR
$9.09B
$53K ﹤0.01%
1,105
-46,440
-98% -$2.24M
LOPE icon
1147
Grand Canyon Education
LOPE
$3.93B
$53K ﹤0.01%
470
LRCX icon
1148
Lam Research
LRCX
$369B
$53K ﹤0.01%
3,550
+700
+25% +$12K
MRTN icon
1149
Marten Transport
MRTN
$1.22B
$53K ﹤0.01%
+3,826
New +$57K
PSI icon
1150
Invesco Semiconductors ETF
PSI
$2.47B
$53K ﹤0.01%
3,033

Similar funds

Geneos Wealth Management's Q3 2018 Portfolio in Review

As of Q3 2018, Geneos Wealth Management held 2,472 positions worth $1.5B, up 17% from $1.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management deployed $156M of net new capital in Q3 2018, opening 220 new positions and adding to 918 existing holdings. Its largest new stake was First Trust Lunt US Factor Rotation ETF: 1,071,026 shares worth $22.2M.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 6.3% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Innovator Lunt Low Vol/High Beta Tactical ETF, an estimated $26.2M trimmed.

  • Geneos Wealth Management's largest Q3 2018 buy was First Trust Lunt US Factor Rotation ETF: 1,071,026 shares worth $22.2M.
  • Geneos Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $13.3M increase.
  • Geneos Wealth Management's biggest Q3 2018 reduction was Innovator Lunt Low Vol/High Beta Tactical ETF, cutting an estimated $26.2M.
  • Geneos Wealth Management fully exited iShares Currency Hedged MSCI Eurozone ETF in Q3 2018, selling an estimated $2.34M.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $1.5B portfolio in Q3 2018.
  • Geneos Wealth Management opened 220 new positions and closed 67 in Q3 2018.
  • Geneos Wealth Management's portfolio value rose 17% quarter-over-quarter to $1.5B.

Based on Geneos Wealth Management's 13F filing for Q3 2018, filed 7 Sep 2021.